Calprotectin Test: Safety, Meaning & What High Levels Mean in Pregnancy
This guide explains the calprotectin stool test, a gut-specific marker for intestinal inflammation. It covers the test's complete safety during... Read more
Author: InnerBuddies
Updated:
Calprotectin testing during pregnancy is a safe, non-invasive stool test that measures intestinal inflammation. Since pregnancy commonly causes bloating, constipation, and changes in bowel habits, this test helps clinicians distinguish normal digestive discomfort from active inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis.
Values below approximately 50 mcg/g are typically considered normal, though thresholds may shift slightly during gestation. Persistently elevated results should be reviewed by your obstetric and gastroenterology care team. For a broader view of digestive wellness, many women pair inflammation tracking with an at-home gut microbiome test to understand how bacterial balance may contribute to symptoms.
Because inflammation patterns evolve across trimesters, longitudinal microbiome testing through a subscription can reveal meaningful trends over time rather than relying on a single snapshot.
For clinics and laboratories looking to expand diagnostic services for pregnant patients, a B2B gut microbiome platform makes advanced stool-based testing accessible at scale.
Always discuss calprotectin findings with your healthcare provider to ensure appropriate follow-up and treatment decisions.
This guide explains the calprotectin stool test, a gut-specific marker for intestinal inflammation. It covers the test's complete safety during... Read more
ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure data
Digestive discomfort is common during pregnancy, which is why new or worsening gut symptoms can be difficult to interpret. When your doctor recommends a stool test, the results can raise more questions than they answer. This article explains calprotectin testing during pregnancy: what fecal calprotectin measures, why it is ordered, whether it is safe, and how normal and elevated results should be understood. You will also learn why gut inflammation deserves extra attention while pregnant, how the gut microbiome changes across trimesters, and how microbiome testing can add personalized context that a single inflammation marker cannot provide on its own.
Fecal calprotectin is a calcium-binding protein found abundantly in neutrophils, a type of white blood cell. When the intestinal lining becomes inflamed, these cells migrate into the gut wall and release calprotectin, which is then excreted in the stool. Because the protein remains stable in stool samples for several days, it serves as a reliable, non-invasive marker of intestinal inflammation and is widely used as a first-line test when inflammatory bowel disease is suspected.
There are three main reasons this test appears in prenatal and digestive care:
Yes. A fecal calprotectin test is a non-invasive stool test during pregnancy: you collect a small sample at home and send it to a laboratory. There is no radiation, no endoscopic procedure, and no physical risk to you or your baby. This makes it one of the safest first steps for investigating digestive symptoms while pregnant.
Pregnancy reshapes digestive physiology. Rising progesterone slows gut motility, immune function is deliberately modulated to tolerate the fetus, and the gut microbiome shifts in parallel. In this environment, separating "normal" pregnancy adjustments from genuine intestinal inflammation becomes both harder and more important, because untreated inflammation in IBD has been associated with poorer outcomes for both mother and baby.
Identifying inflammation early — before symptoms escalate — gives you and your healthcare provider more options. Calprotectin is best understood as an early-warning signal rather than a diagnosis: it indicates that inflammation may be present and that further evaluation could be worthwhile.
In the general adult population, results below roughly 50 µg/g are usually considered normal, with higher values interpreted as borderline or elevated depending on the laboratory. Research suggests that the calprotectin normal range in pregnancy may differ: some studies report mild physiological elevations, particularly in the third trimester, possibly related to changes in the gut lining and immune regulation. Results should therefore always be interpreted by a clinician who knows your gestational age — the same number may carry different meaning at week 12 than at week 36.
Elevated calprotectin during pregnancy can have several possible explanations:
An elevated result does not automatically mean you have IBD. It means inflammation is present somewhere in the intestine, and your doctor may recommend additional assessment to find the source.
Calprotectin has a strong negative predictive value for IBD: a normal result makes active inflammatory bowel disease considerably less likely and can often spare you more invasive procedures. However, it does not confirm that everything in your gut is functioning optimally. Inflammation is only one dimension of gut health — microbial balance, digestion, and motility can still be disrupted, a point that becomes important later in this article.
Abdominal cramping, bloating, changed bowel habits, urgency, mucus in the stool, and unexpected weight changes occur in normal pregnancies, in irritable bowel syndrome (IBS), and in IBD alike. This symptom overlap is precisely why descriptions alone are unreliable, and why a fecal calprotectin test is often ordered when symptoms are persistent or severe.
These symptoms justify prompt medical evaluation rather than watchful waiting.
IBS is a functional disorder without inflammation; IBD is an inflammatory condition that requires active management, especially during pregnancy, when flares have been linked with complications. Because the two can feel identical from the inside, calprotectin testing during pregnancy helps separate them and guides safe, appropriate care.
Calprotectin levels can be influenced by gestational age, recent infections, medications — particularly NSAIDs — diet, intense physical activity, and stress. Different laboratories also use different assays and cutoffs, and collection technique can affect results. Two healthy pregnant women can produce different numbers without either having disease.
Because single results are sensitive to so many variables, clinicians often value repeat testing more than one snapshot. Watching whether a value is rising, falling, or stable adds crucial context. The same logic applies to the microbiome, which is one reason some people choose to track microbiome changes over time rather than relying on a single test.
Bloating, loose stools, and cramping can stem from inflammation, microbial imbalance (dysbiosis), food intolerances, or the hormonal slowing of digestion that pregnancy itself causes. Identical symptoms can reflect completely different mechanisms — and therefore completely different sensible next steps.
Without objective data, expectant mothers often restrict their diets unnecessarily, worry excessively, or dismiss symptoms that actually warranted attention. Objective markers such as calprotectin, combined with broader information about your gut, reduce both the guesswork and the anxiety that usually accompanies it.
Research indicates that the gut microbiome in pregnancy shifts measurably. Early pregnancy tends to resemble the non-pregnant state, while the third trimester often shows reduced microbial diversity, an increase in inflammation-associated bacterial groups, and a rise in bacteria involved in energy harvest. These changes appear to be part of normal physiology, but their magnitude varies substantially between individuals.
Gut bacteria produce short-chain fatty acids such as butyrate, which nourish the cells lining the colon, support the gut barrier, and help regulate immune responses. When microbial balance is disturbed, production of these protective compounds may decline while pro-inflammatory species expand — one pathway through which the microbiome can influence the very intestinal inflammation that calprotectin detects.
Dysbiosis describes a state of reduced microbial diversity, depletion of anti-inflammatory species, or overgrowth of bacteria associated with inflammation. Studies have linked dysbiosis with low-grade intestinal inflammation and impaired barrier function, though much of this evidence is associative, and cause and effect remain an active area of research.
Pregnancy alters the microbiome, and the microbiome in turn can influence metabolic and immune aspects of pregnancy health. For women with IBD, IBS, or persistent unexplained digestive symptoms, understanding this two-way relationship may add meaningful context to otherwise confusing symptoms and test results.
These tests answer different questions and work best together. Calprotectin indicates whether inflammation is present; microbiome analysis describes which bacteria make up your gut ecosystem and which functions they may support. Viewing gut health through a single marker leaves the microbial dimension unexamined.
Like calprotectin testing, microbiome analysis uses an at-home stool sample — no invasive procedure required. The sample is analyzed in a laboratory to identify the bacteria present, and findings are summarized in a report covering your diversity, composition, and functional potential. You can explore what an at-home gut microbiome test involves before deciding whether it fits your situation.
Diversity is often used as a broad indicator of microbial resilience. Lower diversity has been associated with several health conditions, though what counts as "optimal" varies between people — and pregnancy itself naturally shifts composition, so results need trimester-aware context.
Analysis can indicate whether your microbiome is well represented by short-chain-fatty-acid-producing and barrier-supporting bacteria, or whether groups linked with inflammation are overrepresented. This describes potential rather than proven activity, and findings are best read alongside your symptoms and medical history.
Bringing your calprotectin value, your symptoms, and your microbial profile together creates a more coherent picture than any single data point. For many readers, a personalized microbiome analysis is a practical step toward that context — turning isolated numbers into an understandable whole.
Microbiome testing is not necessary for everyone, but it may add useful insight if you:
Testing complements — and never replaces — professional medical care during pregnancy.
Yes. It is a simple stool test collected at home, with no radiation, no endoscopy, and no physical risk to you or your baby. It is considered one of the safest first investigations for digestive symptoms during pregnancy.
Most laboratories use roughly 50 µg/g as the upper limit of normal, though exact cutoffs vary. Some research suggests mild elevations can occur in healthy pregnancies, particularly in the third trimester, so interpretation should always factor in gestational age.
It may. Studies indicate that physiological changes in late pregnancy can produce modestly higher calprotectin values without any underlying disease. This is one reason borderline results should be interpreted by a clinician familiar with pregnancy-specific reference considerations.
It means intestinal inflammation is present somewhere, with possible causes including an IBD flare, an intestinal infection, or recent NSAID use. It is a prompt for further evaluation rather than a diagnosis on its own.
It can help significantly. IBS does not involve intestinal inflammation, so normal calprotectin makes IBD unlikely and points toward a functional cause such as IBS, while elevated results warrant further IBD-focused assessment.
No. It primarily reduces the likelihood of active intestinal inflammation such as IBD. Issues related to microbial balance, motility, digestion, or food tolerance can still exist even when inflammation markers are normal.
Yes, microbiome tests use an at-home stool sample and are non-invasive. Results should be interpreted with pregnancy in mind, since the microbiome naturally changes across trimesters.
Research suggests diversity often decreases by the third trimester, with increases in inflammation-associated groups and energy-harvesting bacteria. These shifts appear to be part of normal pregnancy physiology, though their extent varies between individuals.
Calprotectin tells you whether inflammation is present; microbiome testing describes the composition and functional potential of your gut ecosystem. Together they help address both the presence and the possible context of gut disturbance.
No. Microbiome testing is an educational and insight-generating tool. It describes your microbial profile but does not diagnose disease, and results should always be discussed with a healthcare provider.
Seek prompt medical attention for blood in the stool, fever, nighttime diarrhea, severe or localized pain, or unintended weight loss. Persistent milder symptoms also deserve discussion rather than simply waiting for them to pass.
Calprotectin testing during pregnancy answers one crucial question — is intestinal inflammation present? — while the microbiome helps explore the fuller "why" behind your symptoms. Neither test alone tells the whole story, and no single number captures the reality of an individual gut, especially during a period of such profound biological change. Digestive symptoms in pregnancy are not something to simply endure in confusion; they are a genuine opportunity for insight. Because every pregnancy gut is different, understanding your own microbiome can turn vague worry into a personalized picture of your gut health — one that supports informed, confident conversations with your healthcare provider. This article is for educational purposes only and is not a substitute for professional medical advice.
calprotectin testing during pregnancy, fecal calprotectin in pregnancy, elevated calprotectin during pregnancy, calprotectin normal range pregnancy, gut health during pregnancy, intestinal inflammation, IBD in pregnancy, IBS vs IBD, stool test during pregnancy, gut microbiome pregnancy, microbiome diversity, dysbiosis, gut barrier, short-chain fatty acids, personalized gut health, microbiome testing
Full microbiome sequencing + Gut Health Index. Metabolic pathways, diversity, keystone species. Personalized plans available (diet, supplements, diary, recipes). EU lab + Maastricht University spin-off + GDPR-safe.
Get the latest gut-health tips and be the first to know about new collections and exclusive offers.